Biodock's cloud platform accelerates microscopy analysis, automating months of microscopy analysis and infrastructure to minutes with our end-to-end AI architecture. Scientists enjoy auto-scaling storage, GPU compute, and 30-50% more accurate analysis.
Biodock is a Y Combinator company in the Winter 2021 batch. Its directory entry describes it as: Cloud AI microscopy automation. The founder listed is Nurlybek Mursaliyev (Founder) (Y Combinator directory entry, March 2, 2021).
Get an email when Biodock changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
Biodock's cloud platform accelerates microscopy analysis, automating months of microscopy analysis and infrastructure to minutes with our end-to-end AI architecture. Scientists enjoy auto-scaling storage, GPU compute, and 30-50% more accurate analysis.
We're building an amazing experience to translate microscopy images to therapeutic insights for academic and enterprise scientists.
Biodock lists 3 open roles on its directory entry.
Checked away from the directory entry. Neither line below comes from the company's Y Combinator page.
Biodock makes deep AI easy to train, run, and interpret on biological images, dramatically accelerating your R&D analysis.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Counted only where a thread links to this company's own site, announces it by name on that forum, or names it beside its own Y Combinator batch. A thread whose title merely carries the words is not counted — a name is not an identifier. Hacker News is not us, and nothing above is our opinion of the company.
Nurlybek Mursaliyev
Founder
I have a Ph.D. in Cell and Molecular Biology from the Stanford University Department of Biology. My research focus was on stem cell biology and embryo development. I have experienced firsthand the problem we are solving with Biodock while doing my Ph.D. Previously, I also co-founded a med-tech company SmartLens but decided to focus on my Ph.D. I am also a history nerd and love visiting historical places.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 65 companies held here in Healthcare › Therapeutics.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Biodock?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Biodock: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biodock covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Biodock: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
